NCT07213609
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07213609
Title A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Canton Ohio 44718 United States Details
GSK Investigational Site RECRUITING Nashville Tennessee 37203 United States Details
GSK Investigational Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site RECRUITING Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site RECRUITING Chiba 277-8577 Japan Details
GSK Investigational Site RECRUITING Osaka 573-1191 Japan Details
GSK Investigational Site RECRUITING Tokyo 104-0045 Japan Details
GSK Investigational Site RECRUITING Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field